𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CYP17A1T-34C polymorphism is not associated with endometrial cancer risk

✍ Scribed by Xueying Yang, Aihua Feng, Fengying Liu, Qun Li, Jing Zhang, Chuanhua Yang…

Book ID
120719525
Publisher
S. Karger AG
Year
2013
Tongue
English
Weight
240 KB
Volume
34
Category
Article
ISSN
1010-4283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A polymorphism in the CYP17 gene is asso
A polymorphism in the CYP17 gene is associated with prostate cancer risk
✍ Andrea Gsur; Gabriele Bernhofer; Sonja Hinteregger; Gerald Haidinger; Georg Scha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 63 KB 👁 2 views

CYP17 encodes the enzyme cytochrome P-450c17␣, which mediates both 17␣-hydroxylase and 17,20-lyase in the steroid biosynthesis pathway. A polymorphism in the 5 promoter region of the CYP17 gene has been described. Steroid hormones, especially androgens, are believed to play a key role in the etiolog

CDH1 c-160a promotor polymorphism is not
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer
✍ Paul D.P. Pharoah; Carla Oliveira; José Carlos Machado; Gisella Keller; Holger V 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB

We have combined data from case control studies designed to test the hypothesis that the c-160a promotor polymorphism in the gene coding for the cell adhesion molecule E-cadherin (CDH1) is associated with stomach cancer. A total of 899 individuals (433 patients and 466 controls) were analyzed. The g